Gastroenteritis  >>  Monofer (iron isomaltoside 1000)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Monofer (iron isomaltoside 1000) / Pharmacosmos
NCT01213680: Open-label PK Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg IV Infusion to Patients With Inflammatory Bowel Disease

Completed
1
16
RoW
Monofer (iron isomaltoside 1000), Monofer
Pharmacosmos A/S
Inflammatory Bowel Disease
08/12
11/12

Download Options